Last updated 2026-07-26
- Raised $3M Seed round, Aug 2023
- Raised $3.1M grant, Jun 2017
- Raised $100k grant, Jul 2014
Total raised
$6.9M
Last: Undisclosed Round 2023-09
Stage
Seed
Founded
2009
Headcount
3
HQ
Kiryat Tiv'on, Israel
Sector
Health Tech & Life Sciences
About
Carmel Diagnostics is a medtech company that has developed an innovative method for measuring Oxidative Stress (OS) of a biological liquid, a recognized biomarker of health and disease. This OS parameter is measured by TCL (ThermoChemiLuminescence) technology. The company's lead product, Fertissimo TCL Analyzer, is an innovative, noninvasive embryo selection system for the IVF market, aiming to increase successful IVF pregnancies. They are also developing applications for the diagnosis and prognosis of congestive heart failure patients. Carmel Diagnostics is the first company in the world to create a benchtop system that measures oxidative stress in body fluids at the point of care and within minutes.
Funding history · 5 rounds · $6.9M total
2023-08
Seed
$3.0M
2017-06
Grant
$3.1M
2014-07
Grant
$100K
2014-05
Grant
$170K
2012-12
Grant
$600K
Headcount over time
From 3 (2018-07) to 5 (2025-01) · +2 (+67%) · 5 points · source: Finder history + radar grounding
Q&A
- What is Carmel Diagnostics' primary focus?
- Carmel Diagnostics is a medtech company that develops diagnostic platforms to measure oxidative stress levels in body fluids, a recognized biomarker of health and disease.
- What is Carmel Diagnostics' lead product?
- Carmel Diagnostics' lead product is the Fertissimo TCL Analyzer, an innovative, noninvasive embryo selection system for the IVF market, aiming to increase successful IVF pregnancies.
- When was Carmel Diagnostics founded?
- Carmel Diagnostics was founded in January 2009.
- How many employees does Carmel Diagnostics currently have?
- Carmel Diagnostics has 1-10 employees.
- What was the total amount of funding raised by Carmel Diagnostics?
- Carmel Diagnostics has raised a total of $8,556,205 in funding.
- Which investors participated in Carmel Diagnostics' 2017 grant round?
- In May 2017, Carmel Diagnostics received a grant from EU Horizon 2020.
- What is the primary sector of Carmel Diagnostics?
- Carmel Diagnostics operates in the Health Tech & Life Sciences sector.
- Who is a co-founder and CTO of Carmel Diagnostics?
- Sergei Shnizer is a Co-founder and CTO of Carmel Diagnostics.
Team · 1
Sergei Shnizer
Founder · Co-founder, CTO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesConsumersDemographics & FamilyWomen
Business model
B2B
Highlights
1 PatentsVerified
Tags
laboratoriesmedical-devicesmonitoringfertilityheart-failurediagnosticsmedical-technologieswomenwomen-healthnon-invasivebiomarkersdigital-healthcaregynecologycardiologydecision-supportfemtech
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | carmel-diagnostics.com |
|---|---|
| linkedin.com/company/1558211 | |
| facebook.com/Carmel-Diagnostics-1682162225237831 | |
| YouTube | youtube.com/channel/UCXo7DRLIHS7Vih_H-DDyOhQ |
Identifiers & details
| Legal name | Carmel Diagnostics Ltd. |
|---|---|
| Former names | Lumitest |
| Founded | 2009-1 |
| Employees (exact) | 3 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | carmel-diagnostics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514242338 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2009-02-15 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 2 — violation (1), people (1) |
| Registered address | ברלב חיים 9 קריית טבעון |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |
| 2026-01-15 | עדכון בעלי תפקידים |